Davis Capital Management
LLY icon

Davis Capital Management’s Eli Lilly LLY Stock Holding History

Davis Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$49.8K Sell
43
-18
-30% -$21.2K 0.03% 156
2026
Q2 		$73.2K Buy
61
+48
+369% +$49K 0.04% 135
2026
Q1 		$12K Hold
13
– – 0.01% 209
2025
Q4 		$14K Sell
13
-11
-46% -$10.5K 0.01% 210
2025
Q3 		$18.3K Buy
+24
New +$17.9K 0.01% 194
2025
Q1 		$13.2K Hold
16
– – 0.01% 206
2024
Q4 		$12.4K Sell
16
-100
-86% -$82.8K 0.01% 208
2024
Q3 		$103K Buy
116
+5
+5% +$4.5K 0.08% 98
2024
Q2 		$101K Buy
111
+11
+11% +$8.8K 0.09% 97
2024
Q1 		$76.1K Hold
100
– – 0.07% 104
2023
Q4 		$58.3K Buy
+100
New +$58.4K 0.06% 114
2020
Q2 		$16K Hold
100
– – 0.03% 170
2020
Q1 		$14K Buy
+100
New +$13.7K 0.03% 171

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Davis Capital Management's LLY Position: Q3 2026 in Review

Davis Capital Management reduced its Eli Lilly (LLY) stake by 30% in Q3 2026, selling an estimated $21.2K and leaving 43 shares worth $49.8K. The position accounts for 0.03% of the portfolio, ranked #156.

Davis Capital Management first reported a position in LLY in Q1 2020 and has held it in 13 quarters since. The position peaked at $103K in Q3 2024. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Davis Capital Management held 43 shares of Eli Lilly worth $49.8K as of Q3 2026.
  • Davis Capital Management sold 18 Eli Lilly shares in Q3 2026, an estimated $21.2K.
  • Eli Lilly made up 0.03% of Davis Capital Management's portfolio in Q3 2026, its #156 holding.
  • Davis Capital Management first reported a position in Eli Lilly in Q1 2020 and has held it in 13 quarters since.
  • Davis Capital Management's Eli Lilly position peaked at $103K in Q3 2024.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Davis Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.